Provided by Tiger Trade Technology Pte. Ltd.

Invesco RAFI US 1000 ETF

55.36
+0.27000.49%
Volume:449.38K
Turnover:24.81M
Market Cap:9.94B
PE:34.60
High:55.39
Open:55.00
Low:54.96
Close:55.09
52wk High:56.66
52wk Low:44.11
Shares:179.53M
Float Shares:179.53M
Volume Ratio:0.98
T/O Rate:0.25%
Dividend:0.74
Dividend Rate:1.34%
EPS(TTM):1.60
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Two Key Drivers Fueling a Resurgence of Capital into Banking Stocks

Deep News
·
Jul 07

Crédit Agricole Boosts Stake in Italian Bank Banco BPM to 29.3%

Deep News
·
Jul 06

PRF Technologies Unveils Stronger Preclinical Data for PRF-110 vs. ZYNRELEF

TIPRANKS
·
Jun 26

PRF Technologies Says PRF-110 Showed Comparable Efficacy to Zynrelef in Preclinical Study

MT Newswires Live
·
Jun 25

PRF Technologies announces expanded results from PRF-110 study

TIPRANKS
·
Jun 25

PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

GlobeNewswire
·
Jun 25

PRF Technologies files to sell 7.5M ordinary shares for holders

TIPRANKS
·
Jun 23

PRF Technologies Secures New $15 Million Standby Equity Facility with Yorkville

TIPRANKS
·
Jun 19

Why Is Penny Stock PRF Technologies (PRFX) Up Today?

TIPRANKS
·
May 29

PRF Technologies Speeds DeepSolar Predict Toward Commercial Launch for AI-Driven Renewable Revenue Optimization

TIPRANKS
·
May 28

PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets

GlobeNewswire
·
May 28

PRF Technologies announces results from study comparing PRF-110 to Zynrelef

TIPRANKS
·
May 26

PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

GlobeNewswire
·
May 26

PRF Technologies registers to sell 3M ordinary shares for holders

TIPRANKS
·
May 14

Press Release: First Horizon Declares Cash Dividends on Common and Preferred Stock

Dow Jones
·
Apr 29

PRF Technologies announces FDA clearance of OcuRing-K NDA

TIPRANKS
·
Apr 28

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

GlobeNewswire
·
Apr 28